Biotech Startups

pFIBRE makes flexible packaging films from wood pulp that are designed to biodegrade in seawater. The films are intended as a drop-in substitute for plastic film on existing packaging equipment, giving consumer brands a way to reduce microplastic pollution and address packaging regulations.

1 investor

Phanes Therapeutics develops oncology and metabolic disease therapeutics targeting cell cycle regulators and related pathways. The company operates from San Diego with operations including a research site in Shanghai.

1 investor

A contract drug manufacturing organization (CDMO) specializing in complex pharmaceutical formulations and potent compounds, serving drugmakers from small batches through full-scale production. The company holds FDA licensure and operates multiple manufacturing facilities with capabilities in oral dosage, aseptic processing, and analytical services.

1 investor

PharmaCann is a vertically integrated cannabis company operating cultivation centers, product brands, and retail dispensaries (LivWell and Verilife) serving both medical patients and recreational customers in the United States. It develops and sells cannabis products across the wellness-focused cannabis industry.

1 investor

PhmaPlanter develops biotechnology platforms for recombinant proteins, antibody development, gene editing, nutraceutical research, and advanced cellular technologies including gas vesicles and organoid culture systems.

1 investor

Pharmatest provides preclinical research services for drug development, including cell culture assays and animal models for cancer and skeletal disease research. The company serves pharmaceutical, biotechnology, and nutraceutical companies developing therapeutics and phytopharmaceutical products.

1 investor

Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.

1 investor

Pharosyn uses AI to continuously monitor clinical trials, regulatory filings, press releases, and earnings calls, and produce strategic competitive intelligence reports on a company's competitors. It serves competitive intelligence teams at pharmaceutical and biotech organizations.

1 investor

Phase Biolabs develops biotechnology to convert CO2 into ethanol and other chemicals for use in manufacturing, transportation fuels, and other industrial applications. The company uses biological processes to make carbon recycling economically viable at scale.

1 investor

PHASE Scientific develops diagnostic tools and technologies to improve health information accessibility and accuracy, with expertise in infectious disease prevention, dental health risk assessment, and bioengineering-based diagnostics.

1 investor

1 investor

Phastar is a biometrics and data science contract research organization serving pharmaceutical, biotech, and medical device companies. The firm uses data analytics, AI, and statistical expertise to accelerate clinical trial data management and regulatory approvals.

1 investor

PHC Corporation manufactures life sciences and diagnostic equipment, including ultra-low temperature freezers, CO2 incubators, live cell metabolic analyzers, and point-of-care testing devices for research, medical, and cell/gene therapy applications.

1 investor

PhenoTap develops KetoTap Core, a patent-pending BHB oxidase enzyme designed for reliable, affordable, real-time ketone measurement in blood test strips and continuous monitors. It offers the enzyme as a drop-in technology for device makers building glucose-style sensors, targeting continuous ketone monitoring for health and therapeutic applications.

1 investor

Pheromite develops solutions to help beekeepers combat the varroa mite, using molecular target research and drug design methods such as in silico screening. It serves commercial and hobbyist beekeepers and is based in Auckland, New Zealand.

1 investor

Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.

1 investor

Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.

1 investor

Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.

1 investor

Phoenix PharmaLabs is a pharmaceutical company that welcomes inquiries from organizations seeking business relationships and potential opportunities.

1 investor

Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.

1 investor

1 investor

PhorMed develops next-generation therapies targeting inflammation-driven diseases, particularly rare oncological conditions, using AI-powered targeting technology. The company serves patients with inflammatory and cancer-related diseases, focusing on improving efficacy and safety of first-line treatments.

1 investor

PhosPrint develops bioprinters designed to print bio-inks for tissue engineering applications. The company's Dual Beam I system combines printing and post-processing capabilities for cellular constructs.

1 investor

PhotoPharmics is a clinical-stage medical device company developing non-invasive, light-based photo-neuromodulation therapies for neurodegenerative disease, with a focus on Parkinson's disease. Its investigational device Celeste delivers light through the eyes at home and is being evaluated in clinical trials targeting non-motor symptoms such as sleep, fatigue, and mood.

1 investor